Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Leronlimab (codenamed PRO 140) is a humanized monoclonal antibody targeted against the CCR5 receptor found on T lymphocytes of the human immune system. It is being investigated as a potential therapy in the treatment of triple negative breast cancer and HIV infection.
Development, Mechanism of action & Overview
Explore the main themes, entities and connections around Leronlimab. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
pro 140 cytodyn patients ccr5 hiv antibody trial treatment breast 2019 cancer drug covid-19 viral monoclonal also humanized fda mtnbc
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Leronlimab | ATC code | none | 1.00 | infobox |
| Leronlimab | CAS Number | 674782-26-4 Y | 1.00 | infobox |
| Leronlimab | ChEMBL | ChEMBL2109343 | 1.00 | infobox |
| Leronlimab | ChemSpider | none | 1.00 | infobox |
| Leronlimab | DrugBank | DB05941 Y | 1.00 | infobox |
| Leronlimab | KEGG | D11399 | 1.00 | infobox |
| Leronlimab | NIAID ChemDB | 088103 | 1.00 | infobox |
| Leronlimab | Other names | PRO 140 | 1.00 | infobox |
| Leronlimab | Source | Humanized | 1.00 | infobox |
| Leronlimab | Target | CCR5 | 1.00 | infobox |
| Leronlimab | Type | Whole antibody | 1.00 | infobox |
| Leronlimab | UNII | Y1J4NP8FF0 | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.